Clinical Trial Update: Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the Congo [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update to evaluate the safety and immunogenicity of the MVA-SIBP vaccine for Monkeypox in the Democratic Republic of the Congo; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monkeypox

Drugs mentioned

• MVA-SIBP vaccine

Snippet

Sponsor: Shanghai Institute Of Biological Products | Conditions: Monkeypox (Mpox) | Phase 2 | Status: NOT_YET_RECRUITING